191 related articles for article (PubMed ID: 34385975)
1. Lateralization of Motor Signs Affects Symptom Progression in Parkinson Disease.
Elkurd M; Wang J; Dewey RB
Front Neurol; 2021; 12():711045. PubMed ID: 34385975
[No Abstract] [Full Text] [Related]
2. Probable REM Sleep Behavior Disorder Is a Risk Factor for Symptom Progression in Parkinson Disease.
Barasa A; Wang J; Dewey RB
Front Neurol; 2021; 12():651157. PubMed ID: 33897604
[No Abstract] [Full Text] [Related]
3. Assessing the relationship between non-motor symptoms and health-related quality of life in Parkinson's disease: a retrospective observational cohort study.
Ueno T; Kon T; Haga R; Nishijima H; Arai A; Tomiyama M
Neurol Sci; 2020 Oct; 41(10):2867-2873. PubMed ID: 32328832
[TBL] [Abstract][Full Text] [Related]
4. Predicting the Progression of Parkinson's Disease MDS-UPDRS-III Motor Severity Score from Gait Data using Deep Learning.
Zia Ur Rehman R; Rochester L; Yarnall AJ; Del Din S
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():249-252. PubMed ID: 34891283
[TBL] [Abstract][Full Text] [Related]
5. Progression of MDS-UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort.
Holden SK; Finseth T; Sillau SH; Berman BD
Mov Disord Clin Pract; 2018; 5(1):47-53. PubMed ID: 29662921
[TBL] [Abstract][Full Text] [Related]
6. The association between Parkinson's disease symptom side-of-onset and performance on the MDS-UPDRS scale part IV: Motor complications.
Bay AA; Hart AR; Michael Caudle W; Corcos DM; Hackney ME
J Neurol Sci; 2019 Jan; 396():262-265. PubMed ID: 30537631
[TBL] [Abstract][Full Text] [Related]
7. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's Disease Progression and Statins: Hydrophobicity Matters.
Lewis MM; Albertson RM; Du G; Kong L; Foy A; Huang X
J Parkinsons Dis; 2022; 12(3):821-830. PubMed ID: 34958045
[TBL] [Abstract][Full Text] [Related]
9. Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease.
Zhang F; Wang F; Li W; Wang N; Han C; Fan S; Li P; Xu L; Zhang J; Meng F
BMC Neurol; 2021 Mar; 21(1):122. PubMed ID: 33731033
[TBL] [Abstract][Full Text] [Related]
10. Clinical Progression of Parkinson's Disease: Insights from the NINDS Common Data Elements.
Lewis MM; Harkins E; Lee EY; Stetter C; Snyder B; Corson T; Du G; Kong L; Huang X
J Parkinsons Dis; 2020; 10(3):1075-1085. PubMed ID: 32538866
[TBL] [Abstract][Full Text] [Related]
11. The Key Determinants to Quality of Life in Parkinson's Disease Patients: Results from the Parkinson's Disease Biomarker Program (PDBP).
He L; Lee EY; Sterling NW; Kong L; Lewis MM; Du G; Eslinger PJ; Huang X
J Parkinsons Dis; 2016 May; 6(3):523-32. PubMed ID: 27258700
[TBL] [Abstract][Full Text] [Related]
12. Self-Report versus Clinician Examination in Early Parkinson's Disease.
Zolfaghari S; Thomann AE; Lewandowski N; Trundell D; Lipsmeier F; Pagano G; Taylor KI; Postuma RB
Mov Disord; 2022 Mar; 37(3):585-597. PubMed ID: 34897818
[TBL] [Abstract][Full Text] [Related]
13. Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson's disease: An open-label study.
Juhász A; Aschermann Z; Ács P; Janszky J; Kovács M; Makkos A; Harmat M; Tényi D; Karádi K; Komoly S; Takáts A; Tóth A; Nagy H; Klivényi P; Dibó G; Dézsi L; Zádori D; Annus Á; Vécsei L; Varannai L; Kovács N
Parkinsonism Relat Disord; 2017 Apr; 37():79-86. PubMed ID: 28185758
[TBL] [Abstract][Full Text] [Related]
14. Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.
Wills AM; Pérez A; Wang J; Su X; Morgan J; Rajan SS; Leehey MA; Pontone GM; Chou KL; Umeh C; Mari Z; Boyd J;
JAMA Neurol; 2016 Mar; 73(3):321-8. PubMed ID: 26751506
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and quality of life in Chinese patients with Parkinson's disease beyond 20 years.
Ou R; Hou Y; Song W; Wei Q; Chen Y; Cao B; Yuan X; Shang H
Neurol Res; 2018 Apr; 40(4):312-317. PubMed ID: 29447582
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Change and Progression Indicators Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale in Two Independent Cohorts with Early Parkinson's Disease.
Bartl M; Dakna M; Schade S; Wicke T; Lang E; Ebentheuer J; Weber S; Trenkwalder C; Mollenhauer B
J Parkinsons Dis; 2022; 12(1):437-452. PubMed ID: 34719511
[TBL] [Abstract][Full Text] [Related]
17. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
[TBL] [Abstract][Full Text] [Related]
18. L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression.
Malek N; Kanavou S; Lawton MA; Pitz V; Grosset KA; Bajaj N; Barker RA; Ben-Shlomo Y; Burn DJ; Foltynie T; Hardy J; Williams NM; Wood N; Morris HR; Grosset DG;
Parkinsonism Relat Disord; 2019 Aug; 65():55-61. PubMed ID: 31105012
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease.
Skorvanek M; Rosenberger J; Minar M; Grofik M; Han V; Groothoff JW; Valkovic P; Gdovinova Z; van Dijk JP
J Neurol Sci; 2015; 353(1-2):87-91. PubMed ID: 25918077
[TBL] [Abstract][Full Text] [Related]
20. Association between fatigue and MDS-UPDRS in individuals with Parkinson's disease: cross-sectional study.
Terra MB; Lopes J; Bueno MEB; Trinca LA; Smaili SM
Neurol Sci; 2024 Mar; ():. PubMed ID: 38528282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
